Haemonetics Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4050241003
USD
58.90
-1.15 (-1.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
338.97
327.31
321.39
330.60
348.54
345.51
336.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
338.97
327.31
321.39
330.60
348.54
345.51
336.17
Raw Material Cost
147.56
143.89
140.93
148.68
164.20
166.57
169.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.12
7.21
4.07
0.00
11.09
8.51
5.71
Selling and Distribution Expenses
107.56
101.62
109.75
114.50
105.97
105.92
107.98
Other Expenses
0.62
0.73
1.15
1.60
0.47
0.80
0.87
Total Expenditure (Excl Depreciation)
269.41
260.04
266.26
279.13
286.00
289.02
291.79
Operating Profit (PBDIT) excl Other Income
69.6
67.30000000000001
55.099999999999994
51.5
62.5
56.5
44.400000000000006
Other Income
0.00
0.00
0.00
3.10
0.00
1.62
-0.16
Operating Profit (PBDIT)
96.95
95.53
83.90
82.77
91.57
87.33
73.36
Interest
8.12
7.21
4.07
0.00
11.09
8.51
5.71
Exceptional Items
-1.46
-8.78
-5.90
16.18
-1.54
-4.90
8.20
Gross Profit (PBDT)
191.41
183.42
180.47
181.92
184.34
178.94
166.82
Depreciation
27.39
28.25
28.76
28.21
29.02
29.22
29.14
Profit Before Tax
59.98
51.28
45.17
70.74
49.92
44.70
46.71
Tax
15.23
12.60
11.14
12.76
12.42
10.87
8.34
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.74
38.68
34.03
57.98
37.49
33.83
38.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
44.74
38.68
34.03
57.98
37.49
33.83
38.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.74
38.68
34.03
57.98
37.49
33.83
38.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
911.45
849.17
882.30
820.84
906.86
878.85
905.37
Earnings per share (EPS)
0.95
0.81
0.7
1.17
0.74
0.66
0.74
Diluted Earnings per share
0.95
0.81
0.7
1.17
0.74
0.66
0.74
Operating Profit Margin (Excl OI)
20.52%
20.55%
17.16%
15.57%
17.94%
16.35%
13.2%
Gross Profit Margin
25.77%
24.3%
23.0%
29.93%
22.65%
21.39%
22.56%
PAT Margin
13.2%
11.82%
10.59%
17.54%
10.76%
9.79%
11.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.57% vs 1.84% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 15.50% vs 13.82% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 1.47% vs 13.83% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 12.50% vs 75.61% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Haemonetics Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
338.97
750.60
-411.63
-54.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
338.97
750.60
-411.63
-54.84%
Raw Material Cost
147.56
337.50
-189.94
-56.28%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.12
10.30
-2.18
-21.17%
Selling and Distribution Expenses
107.56
300.50
-192.94
-64.21%
Other Expenses
0.62
2.18
-1.56
-71.56%
Total Expenditure (Excl Depreciation)
269.41
670.10
-400.69
-59.80%
Operating Profit (PBDIT) excl Other Income
69.56
80.50
-10.94
-13.59%
Other Income
0.00
-5.40
5.40
100.00%
Operating Profit (PBDIT)
96.95
104.20
-7.25
-6.96%
Interest
8.12
10.30
-2.18
-21.17%
Exceptional Items
-1.46
-7.20
5.74
79.72%
Gross Profit (PBDT)
191.41
413.10
-221.69
-53.66%
Depreciation
27.39
29.10
-1.71
-5.88%
Profit Before Tax
59.98
57.60
2.38
4.13%
Tax
15.23
24.70
-9.47
-38.34%
Provisions and contingencies
0
0
0.00
Profit After Tax
44.74
32.90
11.84
35.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
44.74
32.90
11.84
35.99%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.74
32.90
11.84
35.99%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
911.45
3,106.30
-2,194.85
-70.66%
Earnings per share (EPS)
0.95
0.20
0.75
375.00%
Diluted Earnings per share
0.95
0.20
0.75
375.00%
Operating Profit Margin (Excl OI)
20.52%
10.72%
0.00
9.80%
Gross Profit Margin
25.77%
11.55%
0.00
14.22%
PAT Margin
13.20%
4.38%
0.00
8.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 33.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.57% vs 1.84% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -2.73% vs 3.66% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.47 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 15.50% vs 13.82% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 19.20% vs 20.19% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.69 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 1.47% vs 13.83% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 5.79% vs 18.19% in Dec 2024

Quarterly - Interest
Interest 0.81 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 12.50% vs 75.61% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -27.03% vs 208.33% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.52%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024